Coloplast to take quantum leap in core markets with new high-tech products
Kristian Villumsen, CEO of Coloplast, has learned lessons about how to speed up the medtech company’s future innovation, after some challenging development years that are finally culminating in the launch of completely new product types.
by ulrich quistgaard, translated by daniel pedersen
Over the course of the coming financial year, Coloplast will launch three new high-tech products, which the medtech company hopes will revolutionize its core markets within ostomy and continence care, according to chief executive Kristian Villumsen.
An HR expert points to increasing competition for skilled workers combined with their pandemic fatigue as factors behind initiatives like Novo Nordisk’s advanced salary talks, Genmab’s extra day off a month, and Bavarian Nordic’s gift of four vacation days.